Navigation Links
Salk researcher Terry Sejnowski elected to Institute of Medicine
Date:10/14/2008

Terry Sejnowski, Ph.D., professor and head of the Computational Neurobiology Laboratory at the Salk Institute has been elected to the Institute of Medicine, the IOM has announced. Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

"It is a great pleasure to welcome these distinguished and influential individuals to the Institute of Medicine," said IOM President Harvey V. Fineberg. "Members are elected through a highly selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health."

A Howard Hughes Medical Institute investigator, Dr. Sejnowski's lab is interested in understanding how the brain represents the world with information stored in neurons that are distributed across the brain and how new representations are formed through learning algorithms, which are rules for changing the strengths of connections between neurons.

He has created computer models of networks of neurons to explore the mechanisms underlying attention in the awake brain and brain rhythms in the sleeping brain and the links between them. These models also help explain how epilepsy arises from imbalances in brain circuits.

Sejnowski's laboratory has developed new ways of analyzing the sources of electrical and magnetic signals recorded from the scalp and the signals picked up by functional magnetic resonance imaging (fMRI) of the brain that are used routinely by laboratories throughout the world to study normal and abnormal brain function.

Among other things, Dr. Sejnowski is interested in the hippocampus, believed to play a major role in learning and memory, and the cerebral cortex, which holds our knowledge of the world and how to interact with it. In his lab, Sejnowski's team uses sophisticated electrical and chemical monitoring techniques to measure changes that occur in the connections among nerve cells in the hippocampus during a simple form of learning. They use the results of these studies to instruct large-scale computers to mimic how these nerve cells work.

By studying how the resulting computer simulations can perform operations that resemble the activities of the hippocampus, Dr. Sejnowski hopes to gain new knowledge of how the human brain is capable of learning and storing memories. This knowledge ultimately may provide medical specialists with critical clues to combating Alzheimer's disease and other disorders that rob people of the critical ability to remember faces, names, places and events.

Sejnowski is also a fellow of the American Association for the Advancement of Science and has received many honors, including the Wright Prize for interdisciplinary research from Harvey Mudd College, the Hebb Prize and the Neural Network Pioneer Award from the Institute of Electrical and Electronics Engineers. He has published over 300 scientific papers and 12 books, including The Computational Brain, with UC San Diego professor of philosophy, Patricia Churchland.


'/>"/>

Contact: Mauricio Minotta
Minotta@salk.edu
858-453-410-01371
Salk Institute
Source:Eurekalert

Related biology news :

1. Researchers identify proteins involved in new neurodegenerative syndrome
2. Texas researchers and educators head for Antarctica
3. MGH researchers describe new way to identify, evolve novel enzymes
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
6. U of MN researchers discover noninvasive diagnostic tool for brain diseases
7. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
8. Researchers discover new strategies for antibiotic resistance
9. Researchers find new taste in fruit flies: carbonated water
10. Binghamton University researchers investigate evolving malaria resistance
11. Antioxidant to retard wrinkles discovered by Hebrew University researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
(Date:11/19/2016)... DALLAS , Nov. 18, 2016 Securus ... technology solutions for public safety, investigation, corrections and monitoring, ... a smaller competitor, ICSolutions, to have an independent technology ... set, the most modern high tech/sophisticated telephone calling platform, ... tell customers that they do most of what we ...
(Date:11/15/2016)... Nov 15, 2016 Research and Markets has ... to 2021" report to their offering. ... ... Billion by 2021 from USD 6.21 Billion in 2016, growing at ... Growth of the bioinformatics market is driven by the growing demand ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Soligenix, Inc. (OTCQB: ... focused on developing and commercializing products to treat rare ... today that it will be hosting an Investor Webcast ... on the origins of innate defense regulators (IDRs) as ... of oral mucositis and the recently announced and published ...
(Date:12/8/2016)... 2016 Savannah River Remediation LLC group ... NewTechBio,s NT-MAX Lake & Pond Sludge and ... in conjunction with Hexa Armor/ Rhombo cover manufactured ... Pollutant Discharge Elimination System requirements. The ... history of elevated pH levels, above 8.5, especially ...
(Date:12/8/2016)... to fuel Philadelphia,s innovative digital ... Southeastern Pennsylvania (" Ben Franklin "); Independence ... Cross; and Safeguard Scientifics ("Safeguard") (NYSE: SFE ... funding initiative over a four year period to grow ... burgeoning economic vitality in digital health, Ben Franklin ...
(Date:12/7/2016)... ... 07, 2016 , ... ACEA Biosciences, Inc. presented today updated ... trial for its lead drug candidate, AC0010, at the World Conference on Lung ... determine the safety, antitumor activity, and recommended phase II dosage of AC0010 in ...
Breaking Biology Technology: